Human Intervention Studies Unit, Ulster University
Coleraine, Londonderry, BT52 1SA, United Kingdom
NCT Number: NCT03291548
Cardiovascular disease (CVD) is one of the most common chronic diseases in older populations, which has been increasing in line with rising overweight and obesity levels in recent years. Dietary intake is a major modifiable risk factor for CVD, and one such recommendation is to increase the intake of essential (omega-3) polyunsaturated fats in our diets, for example by consuming more oily fish. We know, however, from large population level dietary surveys, that many individuals within the United Kingdom (UK) population are not consuming enough oily fish. Therefore, alternative dietary sources of omega-3 polyunsaturated fats are required to help meet consumer needs.
Quinoa is a traditional Andean seed crop consumed in a similar fashion to staple cereal grains in Europe, and the popularity of quinoa has been growing worldwide because of its nutritional content and perceived healthiness. Quinoa contains a small amount of fat, but the ratio of omega-6 and omega-3 essential fats is more favourable in quinoa than in other plant oils. An opportunity therefore exists to incorporate quinoa flour into more frequently consumed food products (e.g. biscuits) as an alternative means of increasing consumers omega-3 intake.
The purpose of this study is to investigate the effect of consuming quinoa-enriched biscuits, compared to control, on markers of CVD risk over 4-weeks in older adults.
Looking for future studies?
Notify Me50 year–75 year
All sexes
Interventional
Not applicable
Coleraine, Londonderry, BT52 1SA, United Kingdom
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
2x15g biscuits per day for 28 consecutive days (4 weeks).
2x15g biscuits per day for 28 consecutive days (4 weeks).
Time frame: Change from baseline compared to control arm
Plasma cholesterol
Time frame: Change from baseline compared to control arm
measured in plasma
Time frame: Change from baseline compared to control arm
measured in plasma
Time frame: Change from baseline compared to control arm
measured in plasma
Time frame: Change from baseline compared to control arm
measured in plasma
Time frame: Change from baseline compared to control arm
measured in plasma
Time frame: Change from baseline compared to control arm
Ferric-reducing Ability Plasma
Time frame: Change from baseline compared to control arm
C-reactive protein
Time frame: Change from baseline compared to control arm
Diastolic and systolic
Time frame: Change from baseline compared to control arm
Kg
University of Ulster
Other
Effect of a Quinoa-enriched Biscuit as Novel Food Product to Improve CVD Risk Markers in Older Adults: a Randomised Crossover Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06380322
Cardiovascular Diseases, Diabetes Mellitus
Fort Carson, Colorado, United States
View Trial DetailsNCT07649577
Asthma, Bronchial Diseases
Amman, Jordan
View Trial DetailsNCT05622929
Arterial Occlusive Diseases, Arteriosclerosis
Salvador, Estado de Bahia, Brazil
View Trial DetailsNCT07175766
Cardiovascular Diseases, Dyslipidemias
Taoyuan, Taiwan
View Trial Details